Literature DB >> 26140085

Induced immunity against hepatitis B virus.

Zeinab Nabil Ahmed Said1, Kouka Saadeldin Abdelwahab1.   

Abstract

Prevention of hepatitis B virus (HBV) infection with its consequent development of HBV chronic liver disease and hepatocellular carcinoma is a global mandatory goal. Fortunately, safe and effective HBV vaccines are currently available. Universal hepatitis B surface antigen HBV vaccination coverage is almost done. Growing knowledge based upon monitoring and surveillance of HBV vaccination programs has accumulated and the policy of booster vaccination has been evaluated. This review article provides an overview of the natural history of HBV infection, immune responses and the future of HBV infection. It also summarizes the updated sources, types and uses of HBV vaccines, whether in the preclinical phase or in the post-field vaccination.

Entities:  

Keywords:  Booster and therapeutic vaccination; Hepatitis B surface antigen; Hepatitis B virus; Hepatitis B virus vaccines; Immunological memory

Year:  2015        PMID： 26140085      PMCID： PMC4483547          DOI： 10.4254/wjh.v7.i12.1660

Source DB:  PubMed          Journal:  World J Hepatol


  88 in total

1.  Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.

Authors:  Christopher P Desmond; Silvana Gaudieri; Ian R James; Katja Pfafferott; Abha Chopra; George K Lau; Jennifer Audsley; Caroline Day; Sarah Chivers; Adam Gordon; Peter A Revill; Scott Bowden; Anna Ayres; Paul V Desmond; Alexander J Thompson; Stuart K Roberts; Stephen A Locarnini; Simon A Mallal; Sharon R Lewin
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Hepatitis B immunization strategies: timing is everything.

Authors:  Christopher O Mackie; Jane A Buxton; Sayali Tadwalkar; David M Patrick
Journal:  CMAJ       Date:  2009-01-20       Impact factor: 8.262

Review 3.  New therapeutic vaccination strategies for the treatment of chronic hepatitis B.

Authors:  Jia Liu; Anna Kosinska; Mengji Lu; Michael Roggendorf
Journal:  Virol Sin       Date:  2014-01-17       Impact factor: 4.327

Review 4.  Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination.

Authors:  D J West; G B Calandra
Journal:  Vaccine       Date:  1996-08       Impact factor: 3.641

5.  [Characterization of HBsAbs in occult hepatitis B virus infection].

Authors:  Zhen-hua Zhang; Xi-ping Zhao; Jian-Bo Xia; Xu Li; Meng-ji Lu; Dong-liang Yang
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2011-07

Review 6.  Global control of hepatitis B virus infection.

Authors:  Jia-Horng Kao; Ding-Shinn Chen
Journal:  Lancet Infect Dis       Date:  2002-07       Impact factor: 25.071

Review 7.  Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications.

Authors:  Teresa Pollicino; Irene Cacciola; Francesca Saffioti; Giovanni Raimondo
Journal:  J Hepatol       Date:  2014-05-05       Impact factor: 25.083

8.  Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment.

Authors:  Solomon Chih-Cheng Chen; Mehlika Toy; Jennifer M Yeh; Jung-Der Wang; Stephen Resch
Journal:  Pediatrics       Date:  2013-03-25       Impact factor: 7.124

9.  Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.

Authors:  P Fisicaro; C Valdatta; C Boni; M Massari; C Mori; A Zerbini; A Orlandini; L Sacchelli; G Missale; C Ferrari
Journal:  Gut       Date:  2009-02-06       Impact factor: 23.059

10.  Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.

Authors:  A Penna; F V Chisari; A Bertoletti; G Missale; P Fowler; T Giuberti; F Fiaccadori; C Ferrari
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307
View more
  13 in total

1.  Need to take special care of non-responders to hepatitis B vaccination among health-care workers, students and chronic patients.

Authors:  Angela Bechini; Paolo Bonanni; Maddalena Grazzini; Diana Paolini; Giulio Arcangeli; Nicola Mucci; Costanza Bini; Emilia Tiscione; Beatrice Zanella; Sara Boccalini
Journal:  Hum Vaccin Immunother       Date:  2020-12-03       Impact factor: 3.452

2.  Humoral Immune Memory to Hepatitis B Vaccine after Primary Vaccination of Children and Adolescents in Assiut, Egypt.

Authors:  Iman I Salama; Samia M Sami; Safaa M Elserougy; Hanaa M Emam; Somaia I Salama; Hazem M Elhariri; Samia A Hemeda; Amal I Hassanain; Aida M Abdel Mohsen; Walaa A Fouad; Lobna A El Etreby; Zeinab N Said
Journal:  Oman Med J       Date:  2020-09-30

Review 3.  Eradication Strategies for Chronic Hepatitis B Infection.

Authors:  Eleanor M P Wilson; Lydia Tang; Shyam Kottilil
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

4.  Urinary polycyclic aromatic hydrocarbons concentrations and hepatitis B antibody serology in the United States (NHANES, 2003-2014).

Authors:  Faye V Andrews; Ellen Smit; Barrett M Welch; Sharia M Ahmed; Molly L Kile
Journal:  Environ Res       Date:  2021-02-01       Impact factor: 6.498

5.  Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20.

Authors:  Daniela Stadler; Martin Kächele; Alisha N Jones; Julia Hess; Christian Urban; Jessica Schneider; Yuchen Xia; Andreas Oswald; Firat Nebioglu; Romina Bester; Felix Lasitschka; Marc Ringelhan; Chunkyu Ko; Wen-Min Chou; Arie Geerlof; Maarten A van de Klundert; Jochen M Wettengel; Peter Schirmacher; Mathias Heikenwälder; Sabrina Schreiner; Ralf Bartenschlager; Andreas Pichlmair; Michael Sattler; Kristian Unger; Ulrike Protzer
Journal:  EMBO Rep       Date:  2021-05-09       Impact factor: 8.807

6.  A Cross-Sectional Survey on Occupational Blood and Body Fluid Exposure Risk in a Tertiary Hospital in East Malaysia.

Authors:  Che Wan Ilmiyah C W Ahmad; Khamisah Awang Lukman; Raja Muhammad Raja Omar; Mohammad Saffree Jeffree
Journal:  Risk Manag Healthc Policy       Date:  2021-02-25

Review 7.  Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-Screened.

Authors:  Soheil Tavakolpour; Seyed Moayed Alavian; Shahnaz Sali
Journal:  Hepat Mon       Date:  2016-03-26       Impact factor: 0.660

8.  Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?

Authors:  Yonas Bekele; Rebecka Lantto Graham; Sandra Soeria-Atmadja; Aikaterini Nasi; Maurizio Zazzi; Ilaria Vicenti; Lars Naver; Anna Nilsson; Francesca Chiodi
Journal:  Front Immunol       Date:  2018-01-10       Impact factor: 7.561

9.  Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161++TCR iVα7.2+ Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection.

Authors:  Yean K Yong; Alireza Saeidi; Hong Y Tan; Mohamed Rosmawati; Philip F Enström; Rami Al Batran; V Vasuki; Indranil Chattopadhyay; Amudhan Murugesan; Ramachandran Vignesh; Adeeba Kamarulzaman; Jayakumar Rajarajeswaran; Abdul W Ansari; Jamuna Vadivelu; James E Ussher; Vijayakumar Velu; Marie Larsson; Esaki M Shankar
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

10.  Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody.

Authors:  Urvi S Zankharia; Sagar Kudchodkar; Makan Khoshnejad; Alfredo Perales-Puchalt; Hyeree Choi; Michelle Ho; Faraz Zaidi; Kenneth E Ugen; Joseph J Kim; David B Weiner; Kar Muthumani
Journal:  Hum Vaccin Immunother       Date:  2020-05-28       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.